Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19911560 | 0.90 | SLC9A1 (0.61) | SLC9A1CYP2C19FGFR1BRD4POLB | |
| SCHEMBL19911571 | 0.87 | SLC9A1 (0.45) | SLC9A1CYP2C19FGFR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL11439834 | 0.85 | SLC9A1 (0.70) | SLC9A1CYP2C19POLBNOD1ALDH1A1 | |
| SCHEMBL19911575 | 0.81 | MGAM (0.43) | FGFR1SMN1; SMN2ALDH1A1KMT2AMEN1 | |
| SCHEMBL11456500 | 0.79 | KMT2A (0.46) | SLC9A1FGFR1POLBSMN1; SMN2ALDH1A1 | |
| SCHEMBL11077590 | 0.78 | SLC9A1 (0.61) | SLC9A1CYP2C19BRD4POLBSMN1; SMN2 | |
| SCHEMBL19911636 | 0.78 | SLC9A1 (0.68) | SLC9A1CYP2C19POLBSMN1; SMN2ALDH1A1 | |
| SCHEMBL19848551 | 0.78 | SLC9A1 (0.68) | SLC9A1CYP2C19BRD4POLBSMN1; SMN2 | |
| SCHEMBL19911490 | 0.78 | SLC9A1 (0.69) | SLC9A1CYP2C19POLBSMN1; SMN2NOD1 | |
| SCHEMBL19911538 | 0.77 | SLC9A1 (0.45) | SLC9A1CYP2C19BRD4SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | BPTF, BRD4, KCNN2 | SLC9A1 341/4885CYP2C19 1476/4885FGFR1 1543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.